William Blair Downgrades Adamas Pharmaceuticals (ADMS) to Market Perform, Following Acquisition Oct 11, 2021 11:05AM
Adamas to Present at Upcoming William Blair Biotech Focus Conference Jul 8, 2021 04:02PM
Adamas to Present at Upcoming June Conferences May 27, 2021 04:11PM
Adamas Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Mar 1, 2021 04:04PM
Adamas Pharma (ADMS) Prices 12.5M Share Follow-On Offering at $4.40/Sh Feb 25, 2021 08:18AM


Feb 24, 2021 09:16PM Adamas Pharmaceuticals Announces Pricing of Follow-on Public Offering
Feb 24, 2021 04:09PM Adamas Pharma (ADMS) Announces Launch of Follow-on Public Offering
Feb 24, 2021 04:08PM Adamas Pharmaceuticals Announces Launch of Follow-on Public Offering
Jun 5, 2020 07:46AM Adamas Pharmaceuticals (ADMS) Reiterated Outperform After Gocovri Accepted for Review - William Blair
Jun 3, 2020 04:01PM Adamas to Present at Upcoming William Blair Conference
Jun 7, 2018 04:30PM Adamas to Present at Two Upcoming Investor Conferences
Jan 23, 2018 09:23AM Pre-Open Movers 01/23: (RGSE) (CNET) (NFLX) Higher; (GPRO) (ADMS) (TWTR) Lower (more...)
Jan 19, 2016 10:49AM Notable Analyst Rating Changes 1/19: (PG) (SHAK) (RF) Upgraded; (MKC) (BBBY) (ESRX) Downgraded
Jan 6, 2016 10:37PM Adamas Pharma (ADMS) Prices 2.5M Shares at $23
Jan 6, 2016 10:08PM Adamas Announces Pricing of Public Offering of Common Stock
Jan 5, 2016 07:15AM Adamas Pharma (ADMS) Announces 2.5M Common Stock Offering
Jan 5, 2016 07:15AM Adamas Announces Proposed Public Offering of Common Stock
May 5, 2014 07:31AM William Blair Starts Adamas Pharmaceuticals (ADMS) at Outperform
Apr 10, 2014 10:28AM Adamas Pharmaceuticals (ADMS) IPO Opens Higher
Apr 10, 2014 08:44AM Adamas Pharmaceuticals (ADMS) IPO Prices at $16, Low End of Range